Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
InMed Pharmaceuticals Inc. - Common Shares
(NQ:
INM
)
2.640
-0.040 (-1.49%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 25, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about InMed Pharmaceuticals Inc. - Common Shares
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Q3 Fiscal 2022 Financial Results, Provides Business Update
May 13, 2022
Via
Investor Brand Network
Topics
Economy
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging Advantage in Rare Cannabinoid Biosynthesis Space
May 09, 2022
Via
Investor Brand Network
Topics
Supply Chain
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Leveraging Advantage in Rare Cannabinoid Biosynthesis Space
May 09, 2022
Via
CannabisNewsWire
Topics
Supply Chain
InMed Commercializes Rare Cannabinoids For Health And Wellness Market
May 09, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Participate in Groundbreaking Study with Trokie and Radicle Science
May 05, 2022
Via
Investor Brand Network
BioMedNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) Transition from Pure-Play Pharma R&D Firm Featured in Research Report
May 04, 2022
Via
Investor Brand Network
InMed Pharmaceuticals (INM): Notable Launches of High-Value Rare Cannabinoids
May 03, 2022
Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence.
From
Edison Investment Research Limited
Via
AccessWire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
May 03, 2022
It's time for another dive into the biggest pre-market stock movers for today as we prepare for a busy day of trading on Tuesday!
Via
InvestorPlace
20 Stocks Moving in Tuesday's Pre-Market Session
May 03, 2022
Gainers Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) shares rose 38% to $3.69 in pre-market trading. Sonoma Pharmaceuticals and MicroSafe Group DMCC reported EPA approval for...
Via
Benzinga
66 Biggest Movers From Yesterday
May 03, 2022
Gainers Better Therapeutics, Inc. (NASDAQ: BTTX) shares surged 120.4% to close at $2.01 on Monday following a 5% drop on Friday. SoundHound AI, Inc. (NASDAQ: SOUN) shares surged...
Via
Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Patent Portfolio with Novel Cannabinoid Analogs, Initiates Strategic Research Collaboration Agreement
April 28, 2022
Via
Investor Brand Network
Topics
Intellectual Property
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expands Patent Portfolio with Novel Cannabinoid Analogs, Initiates Strategic Research Collaboration Agreement
April 28, 2022
Via
CannabisNewsWire
Topics
Intellectual Property
18 Stocks Moving in Tuesday's Pre-Market Session
April 26, 2022
Gainers Q&K International Group Limited (NASDAQ: QK) shares rose 59.2% to $1.56 in pre-market trading after dropping around 5% on Monday. Agile Therapeutics, Inc. (NASDAQ:...
Via
Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Announces Expansion Of Rare Cannabinoid Portfolio
April 22, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Expansion of Rare Cannabinoid Portfolio
April 21, 2022
Via
Investor Brand Network
Topics
Supply Chain
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Expansion of Rare Cannabinoid Portfolio
April 21, 2022
Via
CannabisNewsWire
Topics
Supply Chain
InMed Pharmaceuticals (NASDAQ: INM) Announces Participation In Upcoming Conferences
April 20, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Upcoming Conferences
April 19, 2022
Via
Investor Brand Network
Topics
Cannabis
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Participation in Upcoming Conferences
April 19, 2022
Via
CannabisNewsWire
Topics
Cannabis
InMed Pharmaceuticals (NASDAQ: INM) Expanding Rare Cannabinoid Manufacturing Scale
April 19, 2022
Via
Investor Brand Network
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Rare Cannabinoid Manufacturing Scale
April 18, 2022
Via
CannabisNewsWire
CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Expanding Rare Cannabinoid Manufacturing Scale
April 18, 2022
Via
Investor Brand Network
InMed Pharmaceuticals Committed To Growing Market Reach, Product Portfolio
March 28, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Committed to Growing Market Reach, Product Portfolio
March 28, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Supply Chain
BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Committed to Execute More Programs to Grow Market Reach and Product Portfolio
March 25, 2022
Via
Investor Brand Network
Topics
Intellectual Property
Supply Chain
63 Biggest Movers From Yesterday
March 25, 2022
Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire. Global Internet...
Via
Benzinga
InMed Pharmaceuticals Makes Changes In Management
March 18, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice.
Via
Benzinga
InMed Pharmaceuticals (NASDAQ: INM) Makes Changes in Management
March 18, 2022
Via
Investor Brand Network
InMed Launching Additional Rare Cannabinoids In Response To Demand
March 17, 2022
This post contains sponsored advertising content. This content is for informational purposes only and not intended to be investing advice....
Via
Benzinga
InMed (NASDAQ: INM) Launching Additional Rare Cannabinoids in Response to Demand
March 17, 2022
Via
Investor Brand Network
Topics
Supply Chain
< Previous
1
2
...
8
9
10
11
12
13
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.